About Vero Biotech
Vero Biotech is a company based in Atlanta (United States) founded in 2017.. Vero Biotech has raised $30 million across 2 funding rounds from investors including Runway Growth Capital and Petrichor. The company has 268 employees as of December 31, 2021. Vero Biotech offers products and services including GENOSYL Delivery System. Vero Biotech operates in a competitive market with competitors including Sysadvance, Absstem, Genrich Membranes, Phortman and Tgpoxygen, among others.
- Headquarter Atlanta, United States
- Employees 268 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vero Biotech Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$30 M (USD)
in 2 rounds
-
Latest Funding Round
$30 M (USD), Series B
Jan 11, 2023
-
Investors
Runway Growth Capital
& 1 more
-
Employee Count
268
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vero Biotech
Vero Biotech offers a comprehensive portfolio of products and services, including GENOSYL Delivery System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tankless system for on-demand nitric oxide in pulmonary treatment.
Unlock access to complete
Funding Insights of Vero Biotech
Vero Biotech has successfully raised a total of $30M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in January 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $30.0M
-
First Round
First Round
(12 Jan 2021)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2023 | Amount | Series B - Vero Biotech | Valuation | Petrichor |
|
| Jan, 2021 | Amount | Debt – Conventional - Vero Biotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vero Biotech
Vero Biotech has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Runway Growth Capital and Petrichor. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Petrichor is engaged in supporting healthcare innovation through investments.
|
Founded Year | Domain | Location | |
|
Venture debt financing is provided to companies across multiple sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vero Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Vero Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vero Biotech Comparisons
Competitors of Vero Biotech
Vero Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sysadvance, Absstem, Genrich Membranes, Phortman and Tgpoxygen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of on-site gas generation and gas purifiers
|
|
| domain | founded_year | HQ Location |
Produces PSA generators for medical oxygen and industrial nitrogen supply services.
|
|
| domain | founded_year | HQ Location |
Developer of oxygen enrichment unit
|
|
| domain | founded_year | HQ Location |
Gas outlets for medical gas delivery
|
|
| domain | founded_year | HQ Location |
Medical gases delivery systems and vacuum services are supplied.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vero Biotech
Frequently Asked Questions about Vero Biotech
When was Vero Biotech founded?
Vero Biotech was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Where is Vero Biotech located?
Vero Biotech is headquartered in Atlanta, United States. It is registered at Atlanta, Georgia, United States.
Who is the current CEO of Vero Biotech?
Brent V Furse is the current CEO of Vero Biotech.
Is Vero Biotech a funded company?
Vero Biotech is a funded company, having raised a total of $30M across 2 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $50M, raised on Jan 12, 2021.
How many employees does Vero Biotech have?
As of Dec 31, 2021, the latest employee count at Vero Biotech is 268.
What does Vero Biotech do?
Vero Biotech was established in 2017 in Atlanta, United States, within the biotechnology sector. Inhaled nitric oxide delivery systems are developed by the company for cardiopulmonary applications. GeNOsyl is provided as a specialized system to address persistent pulmonary hypertension of the newborn (PPHN) accompanied by hypoxic respiratory failure. Operations focus on medical device innovation for neonatal care in the United States.
Who are the top competitors of Vero Biotech?
Vero Biotech's top competitors include Absstem, Genrich Membranes and Sysadvance.
What products or services does Vero Biotech offer?
Vero Biotech offers GENOSYL Delivery System.
Who are Vero Biotech's investors?
Vero Biotech has 2 investors. Key investors include Runway Growth Capital, and Petrichor.